Delivery Order SPE2DB20D3505-SPE2DB23FT5U2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.28 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used for the treatment of eye conditions. The contract has a period of performance through January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,812.02 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a pharmaceutical product used in the treatment of various medical conditions. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.53 fixed-price delivery order is for the supply of 5mL bottles of Timolol 0.25% gel-solution, a medication used to treat glaucoma and other eye conditions. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,136.10 firm-fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The award has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,833.35 firm fixed price contract is for the delivery of Timolol 0.25% Gel-Solution, a medication used to treat high eye pressure. The contract has an ultimate completion date of April 4, 2024. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,217.88 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract has an ultimate completion date of November 24, 2023 and was awarded on November 22, 2023. The contract is not designated with any set-aside requirements, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,323.45, is a Firm Fixed Price Delivery Order for the supply of Timolol 0.5% Gel-Solution 5ML, a medication used to treat glaucoma. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,021.26 firm fixed-price delivery order is for the supply of TIMOLOL 0.5% GEL-SOLUTION 5ML, a medication used to treat glaucoma. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,818.42, is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific contract award is for $1,458.14 and covers the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. This contract has no set-aside designation, indicating open competition. AmerisourceBergen, a major...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT5U2Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,795.55 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used to treat certain eye conditions. The contract has a completion date of January 20, 2023 and was awarded on January 19, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/19/23 |